Total Laryngectomy Clinical Trial
Official title:
Effects of Pre-operative Speech-Language Pathology Counselling in Patients Undergoing to Total Laryngectomy: a Randomized Clinical Trial
The investigators aim to verify the effects of pre-operative Speech-Language Pathology (SLP) counselling on patients undergoing total laryngectomy in terms of levels of distress, post-traumatic stress symptoms, anxious-depressive symptoms, acquisition and acceptance of the new voice. This is a randomized controlled trial (RCT) of patients undergoing total laryngectomy and primary tracheoesophageal puncture. Patients will be randomized into two groups: an Experimental group that will receive a pre-operative SLP counselling session and a Control group that will not receive it. The investigators will administer a structured interview and three questionnaires: the Impact of Event Scale - Revised (IES-R), the Psychological Distress Inventory (PDI), the Hospital Anxiety and Depression Scale (HADS). The data will be collected between the 5th and 7th day after surgery (T0), 1-month (T1) and 3-months (T2) after being discharged from hospital.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01948219 -
ENTegral Artificial Larynx Clinical Trial
|
N/A | |
Completed |
NCT02601638 -
Laryngectomy Education
|
N/A | |
Recruiting |
NCT05489965 -
Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
|
||
Recruiting |
NCT04650919 -
Aortic Laryngeal Rehabilitation Graft
|
N/A | |
Terminated |
NCT00661570 -
Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis
|
Phase 2 | |
Completed |
NCT02739958 -
Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx
|
N/A | |
Completed |
NCT00942903 -
Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy
|
Phase 1 | |
Completed |
NCT00884910 -
Long Term Use of the Provox Vega 22.5
|
Phase 2 | |
Completed |
NCT00743262 -
Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis
|
Phase 1/Phase 2 |